Home - Support Center - FAQs

FAQs

Transient vs. Stable Transfection — Speed, Yield, and When Each Makes Sense?

Compare transient and stable transfection for recombinant antibody and protein production. Learn about timeline, yield, cost trade-offs, stable pools as an intermediate, and when to transition from transient to stable expression.
Fc Engineering Explained — Effector Functions, Half-Life, and Silent Fc Variants?

Learn how Fc engineering controls antibody effector functions, serum half-life, and immune activation. Covers ADCC enhancement, afucosylation, silent Fc mutations (LALA, LALA-PG), and FcRn-based half-life extension (YTE, LS).
Antibody Epitope Mapping — Methods, Resolution, and How to Interpret Results?

Compare epitope mapping methods including peptide arrays, HDX-MS, X-ray crystallography, cryo-EM, alanine scanning, and SPR-based binning. Learn when to use each method and how to interpret results.
Protein Aggregation — Causes, Detection Methods, and Prevention Strategies?

Understand why proteins aggregate during biopharmaceutical production, how to detect aggregates with SEC, DLS, and DSF, and practical prevention strategies at the sequence, process, and formulation levels.
ADC Linker-Payload Chemistry — Linker Types, Conjugation Strategies, and Payload Selection?

Explore antibody-drug conjugate (ADC) design including cleavable vs. non-cleavable linkers, tubulin inhibitor and DNA-damaging payloads, site-specific conjugation, DAR optimization, and bystander effect considerations.
Nanobody Engineering — Affinity Maturation, Formatting, and Therapeutic Applications?

Learn nanobody (VHH) engineering strategies including affinity maturation, Fc fusion, albumin-binding half-life extension, humanization, and multivalent formatting for therapeutic, diagnostic, and research applications.
Antibody Developability Assessment — Key Assays, Decision Criteria, and Lead Selection Integration?

Learn how to evaluate antibody developability including thermal stability, aggregation, self-interaction, polyreactivity, viscosity, and chemical stability. Integrate developability data into lead selection to avoid late-stage failures.
Single B Cell Cloning — Technology, Sorting Strategies, and Comparison with Hybridoma and Phage Display?

Understand single B cell antibody cloning including FACS sorting strategies, B cell populations, single-cell RT-PCR gene recovery, and how this approach compares with hybridoma technology and phage display for antibody discovery.
Bispecific Antibody Formats — Structural Designs, Challenges, and Emerging Approaches?

Explore major bispecific antibody formats including knobs-into-holes, BiTE, CrossMAb, and tandem nanobody designs. Learn how to solve chain-pairing challenges and select the right format for your therapeutic program.
Antigen Design for Antibody Generation — Peptide vs. Protein vs. Cell-Based Strategies?

Compare peptide, recombinant protein, and cell-based antigen strategies for antibody generation. Learn how immunogen format affects epitope type, application compatibility, and antibody specificity.

Support Center

Messages

By Method

By Application

FAQs

About Us

Core Technologies

Resource Center